Serum copper levels and epilepsy.
D000086:Acetazolamide / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000661:Amphetamine / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D002570:Ceruloplasmin / Q000032:analysis; D002648:Child; D003300:Copper / Q000097:blood*; D004828:Epilepsies, Partial / Q000097:blood; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D005082:Physical Exertion; D011324:Primidone / Q000627:therapeutic use; D012737:Sex Factors; D013312:Stress, Physiological; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000927:Anticonvulsants; D014149:Tranquilizing Agents; D011324:Primidone; D002110:Caffeine; D003300:Copper; D000661:Amphetamine; D002570:Ceruloplasmin; D000086:Acetazolamide